Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 1/2 7Phase 2 4Phase 3 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 48Genitourinary 28Other hematologic neoplasm 19Lymphoid 10Gastrointestinal 8Breast 7Myeloid 6Gynecologic 5Tumor-Agnostic 4Sarcoma 4CNS 4Thoracic 2Head & Neck 2Plasma cell 1Other solid neoplasm 1NET 1Endocrine 1

Conditions

Neuroblastoma 4Neoplasm, Residual 1

Interventions

Temozolomide 258Radiotherapy 147Bevacizumab 142Etoposide 68Cyclophosphamide 68Carboplatin 66Magnetic Resonance Spectroscopy 58Irinotecan 53Cisplatin 52Vincristine 45Filgrastim 43pembrolizumab 40Radiosurgery 36Nivolumab 36Radiation 34Topotecan 31Doxorubicin 30Specimen Handling 29sargramostim 28Lomustine 27Erlotinib Hydrochloride 27Peripheral Blood Stem Cell Transplantation 25Carmustine 25Thiotepa 24Everolimus 23Chemotherapy, Adjuvant 23Surgical Procedures, Operative 22Isotretinoin 22Ipilimumab 22Melphalan 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Interleukin-2 × CNS × Clear all
NCT01857934 2026-04-16

Therapy for Children With Advanced Stage Neuroblastoma

St. Jude Children's Research Hospital

Phase 2 Completed
153 enrolled 12 charts
CNS

Neuroblastoma

NCT02169609 2024-04-22

Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma

Fundació Sant Joan de Déu

Phase 2 Completed
24 enrolled
CNS

Neuroblastoma, Neoplasm, Residual

NCT00698009 2020-09-24

Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 2 charts
CNS

Neuroblastoma

NCT02771743 2016-05-24

Response-based Treatment of High-risk Neuroblastoma

Samsung Medical Center

Phase 2 Unknown
54 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡